	Prospectos 1 43 1 9724,	
apareci 1 43 1 9722,	
""1612"" 1 43 1 8251,	
rosa 1 43 1 8243,	
241 1 43 1 8218,	
eu/ 1 43 1 8188,	
europa 1 43 1 8187,	
emea 1 43 1 8186,	
//www 1 43 1 8185,	
(EMEA) 1 43 1 8183,	
Medicamentos 1 43 1 8182,	
Europea 1 43 1 8180,	
web 1 43 1 8176,	
página 1 43 1 8175,	
TEXTO 1 43 1 8164,	
REVISIÓN 1 43 1 8162,	
Junio 1 43 1 8155,	
AUTORIZACIÓN/RENOVACIÓN 1 43 1 8149,	
FECHA 2 43 2 8145,8159,	
EU/1/06/343/001 1 43 1 8141,	
EU/1/06/343/006 1 43 1 8140,	
EU/1/06/343/003 1 43 1 8138,	
NÚMERO(S) 1 43 1 8133,	
Unido 1 43 1 8131,	
Reino 1 43 1 8130,	
1DH 1 43 1 8129,	
Road 1 43 1 8126,	
Sanderson 1 43 1 8125,	
Uxbridge 2 43 2 8122,8127,	
PHARMA 1 43 1 8120,	
SQUIBB 1 43 1 8119,	
COMERCIALIZACIÓN 2 43 2 8117,8137,	
AUTORIZACIÓN 3 43 3 8115,8135,8152,	
LA 4 43 4 8114,8147,8151,8161,	
TITULAR 1 43 1 8112,	
normativa 1 43 1 8109,	
acuerdo 1 43 1 8106,	
realizará 1 43 1 8104,	
contacto 1 43 1 8100,	
materiales 1 43 1 8095,	
utilizado 1 43 1 8090,	
tamaños 1 43 1 8074,	
comercializados 1 43 1 8072,	
Puede 1 43 1 8068,	
polipropileno 1 43 1 8051,	
cierre 1 43 1 8049,	
(HDPE) 1 43 1 8047,	
densidad 1 43 1 8046,	
polietileno 1 43 1 8043,	
90 1 43 1 8016,	
perforadas 2 43 2 8008,8033,	
unitarias 2 43 2 8007,8032,	
Alu/Alu 2 43 2 8004,8029,	
blíster 2 43 2 8002,8027,	
láminas 2 43 2 8001,8026,	
película; 2 43 2 7997,8022,	
Cada 2 43 2 7988,8063,	
contenido 1 43 1 7985,	
cerrado 1 43 1 7980,	
frasco 2 43 2 7978,8067,	
Mantener 1 43 1 7976,	
25°C 1 43 1 7975,	
Frasco 3 43 3 7968,8041,8142,	
temperatura 2 43 2 7959,7972,	
Blíster 1 43 1 7955,	
conservación 1 43 1 7954,	
Precauciones 2 43 2 7951,8079,	
procede 1 43 1 7941,	
Polisorbato 1 43 1 7934,	
Macrogol 1 43 1 7932,	
titanio 1 43 1 7930,	
Dióxido 1 43 1 7928,	
pelicular 1 43 1 7927,	
Cubierta 1 43 1 7926,	
Povidona 1 43 1 7925,	
Celulosa 1 43 1 7923,	
Estearato 1 43 1 7920,	
monohidratada 1 43 1 7919,	
Crospovidona 1 43 1 7917,	
Núcleo 1 43 1 7914,	
	6 1 43 1 7909,	
FARMACÉUTICOS 1 43 1 7908,	
http 1 43 1 8184,	
conoce 1 43 1 7905,	
observaciones 1 43 1 7897,	
predictivo 1 43 1 7894,	
precisión 1 43 1 7891,	
establecidos 1 43 1 7889,	
pudieron 1 43 1 7887,	
adenomas 1 43 1 7869,	
hepáticos 2 43 2 7858,7872,	
carcinomas 2 43 2 7857,7871,	
macho/hembras 1 43 1 7856,	
cerebrales 1 43 1 7853,	
especie 1 43 1 7839,	
específico 1 43 1 7836,	
observados 1 43 1 7830,	
patogenia 1 43 1 7825,	
clave 1 43 1 7822,	
evento 1 43 1 7821,	
pulmón 1 43 1 7807,	
validez 1 43 1 7946,	
proliferación 1 43 1 7802,	
precedido 1 43 1 7799,	
hayan 1 43 1 8097,	
estuvo 1 43 1 7798,	
tumores 5 43 5 7774,7797,7828,7849,7862,	
carcinogenicidad 1 43 1 7760,	
Estudios 1 43 1 7758,	
considerablemente 1 43 1 7746,	
clastogénico 1 43 1 7738,	
reparación 1 43 1 7728,	
micronúcleos 1 43 1 7726,	
sirio 1 43 1 7723,	
embrionarias 1 43 1 7720,	
transformación 1 43 1 7717,	
mamífero 1 43 1 7716,	
microbiana 1 43 1 7711,	
mutagenicidad 2 43 2 7710,7712,	
Ames 1 43 1 7708,	
genotoxicidad 1 43 1 7699,	
demostró 1 43 1 7680,	
mg/kg 1 43 1 7678,	
lactantes 1 43 1 7673,	
progenie 1 43 1 7659,	
peri-postnatal 1 43 1 7649,	
13ª 1 43 1 7642,	
costillas 1 43 1 7618,	
lumbares 1 43 1 7616,	
vértebras 1 43 1 7615,	
(vértebras 1 43 1 7608,	
reducida 2 43 2 7607,7632,	
osificación 2 43 2 7606,7631,	
malformaciones 1 43 1 7600,	
fetal 2 43 2 7599,7683,	
(resorciones) 2 43 2 7595,7630,	
embriofetal 2 43 2 7594,7629,	
maternal 1 43 1 7592,	
gestantes 1 43 1 7559,	
conejos 2 43 2 7558,7621,	
evidentes 1 43 1 7546,	
roedores 1 43 1 7530,	
seminíferos) 1 43 1 7520,	
túbulos 1 43 1 7519,	
(degeneración 1 43 1 7516,	
hembra 3 43 3 7508,7867,7875,	
macho 3 43 3 7506,7766,7861,	
ratas 9 43 9 7505,7556,7584,7651,7671,7732,7814,7855,7874,	
reproducción 1 43 1 7481,	
diariamente 1 43 1 7463,	
administró 3 43 3 7461,7486,7668,	
monos 3 43 3 7456,7554,7817,	
especies 1 43 1 7453,	
respectivamente) 1 43 1 7438,	
19 1 43 1 7422,	
exposiciones 9 43 9 7421,7468,7511,7534,7576,7587,7624,7777,7878,	
estableció 1 43 1 7413,	
central 1 43 1 7408,	
toxicología 3 43 3 7393,7478,7525,	
preclínicos 1 43 1 7387,	
etnias 1 43 1 7382,	
estudiaron 1 43 1 7377,	
asiáticos 1 43 1 7372,	
caucásicos 1 43 1 7370,	
aplicarse 1 43 1 7366,	
conclusiones 1 43 1 7363,	
origen 1 43 1 7347,	
influya 2 43 2 7331,7353,	
identificó 2 43 2 7323,7345,	
poblacional 2 43 2 7308,7343,	
farmacocinético 3 43 3 7307,7329,7342,	
29% 1 43 1 7259,	
29 1 43 1 7248,	
jóvenes 3 43 3 7233,7266,7304,	
varones) 2 43 2 7230,7254,	
74 1 43 1 7228,	
(edad 2 43 2 7220,7244,	
83 1 43 1 7218,	
ancianos 3 43 3 7209,7262,7296,	
sujetos 4 43 4 7208,7232,7265,7379,	
comparando 1 43 1 7207,	
evaluó 1 43 1 7196,	
sexos 1 43 1 7193,	
hombres 1 43 1 7162,	
contribuyó 1 43 1 7136,	
alterada 1 43 1 7135,	
Post-trasplante 1 43 1 7091,	
(19 1 43 1 7088,	
5) 1 43 1 7087,	
(16 1 43 1 7086,	
(62 1 43 1 7080,	
(153 1 43 1 7078,	
35 1 43 1 7075,	
226 1 43 1 7069,	
588 1 43 1 7065,	
CLT/F 1 43 1 7064,	
(SD) 2 43 2 7063,7090,	
(10 1 43 1 7061,	
(31 1 43 1 7059,	
(78 1 43 1 7057,	
(101 1 43 1 7055,	
NA 2 43 2 7052,7053,	
135 1 43 1 7048,	
197 1 43 1 7046,	
383 1 43 1 7044,	
CLR 1 43 1 7043,	
(CV) 1 43 1 7042,	
/ml) 1 43 1 7041,	
(ng·h 1 43 1 7040,	
AUC(0-T) 1 43 1 7039,	
51 1 43 1 7029,	
(29 2 43 2 7025,7084,	
(56 1 43 1 7023,	
(37 1 43 1 7017,	
7) 4 43 4 7016,7020,7026,7079,	
(30 1 43 1 7015,	
(CV%) 1 43 1 7014,	
(ng/ml) 1 43 1 7001,	
Grave 3 43 3 6997,6998,6999,	
Moderado 1 43 1 6996,	
afectado 1 43 1 6994,	
farmacocinética 4 43 4 6971,7204,7335,7357,	
6) 3 43 3 7060,7081,7089,	
muestra 1 43 1 6969,	
Diálisis 1 43 1 6954,	
eliminó 2 43 2 6945,6960,	
Un 1 43 1 6938,	
moderada 1 43 1 6911,	
farmacocinéticos 1 43 1 6905,	
alrededor 1 43 1 6897,	
efectiva 1 43 1 6895,	
128 1 43 1 6870,	
terminal 1 43 1 6868,	
eliminación 3 43 3 6867,8082,8086,	
233 1 43 1 7035,	
biexponencial 1 43 1 6862,	
manera 1 43 1 6861,	
descendieron 1 43 1 6859,	
máximos 1 43 1 6853,	
neta 1 43 1 6847,	
glomerular 1 43 1 6843,	
sufre 1 43 1 6841,	
	BRISTOL-MYERS 1 43 1 8118,	
471 1 43 1 6833,	
360 1 43 1 6831,	
oscila 1 43 1 6829,	
independiente 2 43 2 6824,7663,	
aproximadamente 1 43 1 6814,	
orina 1 43 1 6807,	
recuperación 1 43 1 6802,	
Eliminación 1 43 1 6792,	
glucuronidados 1 43 1 6789,	
II 1 43 1 6788,	
fase 1 43 1 6787,	
conjugados 1 43 1 6785,	
acetilados 1 43 1 6777,	
oxidativos 1 43 1 6775,	
metabolitos 2 43 2 6774,6784,	
C14 1 43 1 6770,	
marcado 1 43 1 6768,	
Tras 1 43 1 6763,	
enzimático 1 43 1 6761,	
original 1 43 1 7967,	
13% 2 43 2 6749,6946,	
vitro 1 43 1 6747,	
in 1 43 1 6746,	
magnesio 1 43 1 7922,	
proteínas 1 43 1 6743,	
agua 1 43 1 6737,	
excede 1 43 1 6735,	
volumen 1 43 1 6729,	
Distribución 1 43 1 6727,	
afectar 1 43 1 6714,	
relevante 1 43 1 6701,	
consideró 1 43 1 6699,	
administra 1 43 1 6694,	
20% 1 43 1 6683,	
44 1 43 1 6671,	
ayunas) 1 43 1 6664,	
retraso 1 43 1 6646,	
dio 1 43 1 6642,	
g 2 43 2 6628,6639,	
54 1 43 1 6626,	
sulfatados 1 43 1 6791,	
kcal 2 43 2 6625,6636,	
comida 2 43 2 6619,6633,	
cola 1 43 1 7605,	
indistintamente 1 43 1 6608,	
usarse 1 43 1 6607,	
farmacéuticas 1 43 1 6605,	
demostraron 1 43 1 6595,	
alcanzan 2 43 2 6581,7753,	
respectivamente 2 43 2 6572,6588,	
ng/ml 2 43 2 6571,6587,	
aproximada 1 43 1 6545,	
acumulación 3 43 3 6544,6877,6894,	
alcanza 2 43 2 6529,6813,	
estacionario 2 43 2 6527,6557,	
perivascular 1 43 1 7402,	
repetida 1 43 1 6514,	
AUC 6 43 6 6510,6679,6689,7153,7256,7293,	
Cmáx 5 43 5 6508,6551,6669,6687,7000,	
proporcional 1 43 1 6500,	
estimado 2 43 2 6487,6732,	
inalterado 2 43 2 6484,6805,	
EEIG 1 43 1 8121,	
fármaco 3 43 3 6483,6804,6879,	
urinaria 1 43 1 6481,	
absoluta 1 43 1 6472,	
máximas 1 43 1 6461,	
plasmáticas 2 43 2 6460,6856,	
alcanzando 1 43 1 6458,	
rápidamente 1 43 1 6457,	
Absorción 1 43 1 6453,	
especificado 1 43 1 6448,	
año; 1 43 1 6443,	
entecavir-lamivudine 1 43 1 6332,	
(16%) 1 43 1 6314,	
13 3 43 3 6313,6337,6839,	
(10%) 1 43 1 6312,	
(8%) 1 43 1 6288,	
80 3 43 3 6280,6350,7935,	
187 1 43 1 6278,	
resume 1 43 1 6252,	
bajo) 1 43 1 6233,	
12 3 43 3 6226,6287,7298,	
(aumento 1 43 1 6224,	
rebote 2 43 2 6222,6444,	
Hasta 1 43 1 6212,	
baja 1 43 1 6205,	
existir 1 43 1 6203,	
seleccionar 1 43 1 6195,	
indicando 2 43 2 6187,7818,	
monitorizado 1 43 1 6184,	
refractarios 1 43 1 6172,	
(5%) 1 43 1 6170,	
10/187 1 43 1 6169,	
procedentes 1 43 1 6167,	
nivel 1 43 1 6163,	
ventana 2 43 2 6154,6437,	
sucesivas 2 43 2 6148,6431,	
confirmado 2 43 2 6145,6428,	
d 2 43 2 6144,6410,	
determinado 3 43 3 6141,6425,6476,	
punto 3 43 3 6133,6231,6417,	
Incremento 2 43 2 6127,6411,	
(3er 2 43 2 6118,6401,	
156 2 43 2 6117,6400,	
testiculares 2 43 2 7515,7545,	
año) 4 43 4 6109,6119,6392,6402,	
(22 1 43 1 7019,	
(2º 2 43 2 6108,6391,	
102 4 43 4 6107,6114,6390,6397,	
año); 2 43 2 6100,6383,	
(1er 2 43 2 6099,6382,	
58 4 43 4 6098,6104,6381,6387,	
Incluidos 2 43 2 6075,6358,	
plazo) 2 43 2 6063,6346,	
(seguidas 2 43 2 6056,6339,	
entecavir-lamivudina 1 43 1 6049,	
147 1 43 1 6040,	
virológico 3 43 3 6013,6223,6305,	
cantidades 1 43 1 6780,	
Rebote 2 43 2 6012,6304,	
acumulativa 2 43 2 6000,6295,	
Probabilidad 2 43 2 5999,6294,	
Genotípica 5 43 5 5997,6010,6261,6292,6302,	
ETVr 7 43 7 5996,6009,6018,6291,6301,6316,6439,	
1%) 3 43 3 5989,5992,5995,	
149 4 43 4 5982,6042,6067,6872,	
278 1 43 1 5981,	
663 1 43 1 5980,	
(33 1 43 1 7021,	
Emergente 6 43 6 5962,5998,6011,6262,6293,6303,	
(ETVr)Genotípica 1 43 1 5961,	
rtL180M) 1 43 1 5957,	
(rtM204 1 43 1 5955,	
alteración 1 43 1 7500,	
presencia 1 43 1 5945,	
similares 1 43 1 6915,	
Estas 1 43 1 5939,	
tabla) 1 43 1 5938,	
genotípicas 1 43 1 5910,	
evidencias 1 43 1 5909,	
identificaron 1 43 1 5908,	
determinación 3 43 3 5885,6081,6364,	
había 2 43 2 5879,6183,	
lamivudina) 1 43 1 5874,	
(resistentes 1 43 1 5872,	
nucleósidos) 1 43 1 5867,	
(sin 2 43 2 5863,6983,	
monitorizó 1 43 1 5846,	
(048) 1 43 1 5815,	
abierto 1 43 1 5814,	
marcha 1 43 1 5810,	
actualmente 1 43 1 5807,	
posible 1 43 1 5792,	
futuros 1 43 1 5775,	
elección 1 43 1 5772,	
consecuencias 1 43 1 5769,	
mutante 1 43 1 5762,	
selección 1 43 1 5760,	
monoterapia 1 43 1 5750,	
reducciones 1 43 1 5734,	
37% 1 43 1 5686,	
produjo 1 43 1 5683,	
inicialmente 2 43 2 5653,5854,	
incremento 2 43 2 5644,6499,	
adicional 1 43 1 5610,	
seguido 1 43 1 5606,	
17) 1 43 1 5602,	
placebo 1 43 1 5599,	
grupos 2 43 2 5584,7369,	
11 3 43 3 5577,5647,6285,	
(solo 1 43 1 5558,	
incluyeron 1 43 1 5519,	
incluía 1 43 1 5513,	
seguían 1 43 1 5508,	
recurrente 1 43 1 5504,	
(ARN 1 43 1 5495,	
estable 2 43 2 5492,7111,	
costilla 1 43 1 7643,	
controlado 1 43 1 5489,	
negativo 1 43 1 5482,	
67 1 43 1 5474,	
alterados 1 43 1 5693,	
reciben 2 43 2 5466,7108,	
Poblaciones 1 43 1 5459,	
Edad/Sexo 1 43 1 5425,	
40% 1 43 1 5395,	
77 1 43 1 5378,	
17% 1 43 1 5370,	
221 1 43 1 7037,	
30% 1 43 1 5351,	
considerable 1 43 1 5315,	
(79/253) 1 43 1 5298,	
(131/286) 1 43 1 5287,	
46% 2 43 2 5286,6673,	
027 1 43 1 5281,	
(68/93) 1 43 1 5269,	
73% 1 43 1 5268,	
respondieron 4 43 4 5263,5273,5292,5303,	
madres 1 43 1 7574,	
(83/111) 1 43 1 5258,	
75% 2 43 2 5257,6816,	
período 3 43 3 5248,6153,6436,	
022 1 43 1 5243,	
mantuvo 2 43 2 5239,5283,	
protocolo 1 43 1 5235,	
definidos 1 43 1 5232,	
cumplieron 1 43 1 5227,	
única 2 43 2 6886,6977,	
27% 1 43 1 5208,	
64% 1 43 1 5172,	
28 1 43 1 5151,	
26 3 43 3 5144,7535,8153,	
De 2 43 2 5142,5376,	
84% 1 43 1 5127,	
77% 1 43 1 5114,	
325) 1 43 1 5085,	
14% 1 43 1 7156,	
normalizó 3 43 3 5043,5196,5411,	
164 1 43 1 5022,	
243 1 43 1 5012,	
81% 2 43 2 5009,5417,	
semanas) 3 43 3 5007,5162,5393,	
extensión 2 43 2 6073,6356,	
(media 3 43 3 5004,5159,5390,	
52 3 43 3 5003,5158,5389,	
superando 3 43 3 4999,5155,5386,	
finalizar 1 43 1 4988,	
(3% 1 43 1 4981,	
355) 1 43 1 4942,	
HBsAg) 2 43 2 4934,4986,	
(5% 1 43 1 4929,	
31% 2 43 2 4916,5297,	
normalización 6 43 6 4912,4964,5108,5130,5365,5678,	
87% 1 43 1 4909,	
80% 1 43 1 4898,	
consiguió 3 43 3 4892,5086,5345,	
354) 1 43 1 4891,	
alternativo 1 43 1 4867,	
presentaron 4 43 4 4858,5027,5178,5396,	
30 2 43 2 7991,8058,	
ciegos 1 43 1 4847,	
siguieron 1 43 1 4825,	
respondían 1 43 1 4823,	
negativos) 1 43 1 4819,	
MEq/ml) 1 43 1 4799,	
(ADN 1 43 1 4793,	
segundo 1 43 1 4780,	
semana 15 43 15 4774,5002,5157,5388,5894,5965,6093,6103,6113,6214,6244,6265,6376,6386,6396,	
ratones 4 43 4 7765,7833,7860,7866,	
pre-establecidos 1 43 1 4770,	
criterios 4 43 4 4767,4785,4837,5229,	
Resultados 1 43 1 4751,	
3% 2 43 2 4708,6963,	
61%* 1 43 1 4702,	
19%* 1 43 1 4687,	
-0 1 43 1 4679,	
11* 1 43 1 4678,	
perdieron 1 43 1 5320,	
145 2 43 2 4671,7033,	
141 1 43 1 4670,	
26% 2 43 2 4667,4968,	
16% 1 43 1 4659,	
34% 1 43 1 4658,	
28% 1 43 1 4650,	
Resistentes 1 43 1 4643,	
145) 1 43 1 4631,	
100 3 43 3 4623,7071,7469,	
141) 2 43 2 4618,5344,	
lavado 1 43 1 4613,	
periodos 1 43 1 4611,	
cambiaron 1 43 1 4601,	
posteriores 1 43 1 4752,	
entrar 1 43 1 4596,	
presentaba 1 43 1 4585,	
85% 2 43 2 4581,5362,	
026) 2 43 2 4576,5331,	
aleatorizado 2 43 2 4563,5813,	
cuantificación 2 43 2 4550,4747,	
inferior 2 43 2 4548,4745,	
Amplicor 2 43 2 4545,4742,	
Cobas 2 43 2 4544,4741,	
Roche 2 43 2 4543,4740,	
Ensayo 2 43 2 4542,4739,	
c 10 43 10 4541,4738,5986,6008,6016,6120,6284,6300,6315,6403,	
variable 2 43 2 4537,4734,	
b 4 43 4 4535,4732,6074,6357,	
(puntuación 2 43 2 4526,4723,	
evaluable 2 43 2 4525,4722,	
p 2 43 2 4514,4711,	
*valor 2 43 2 4512,4709,	
21% 2 43 2 4510,5217,	
Seroconversión 2 43 2 4508,4705,	
LSN) 5 43 5 4507,4704,5050,5201,5414,	
continuaron 5 43 5 4620,4846,4995,5381,5572,	
71% 1 43 1 4506,	
60% 1 43 1 4504,	
68%* 1 43 1 4503,	
Normalización 2 43 2 4495,4694,	
PCR)c 2 43 2 4494,4693,	
300 12 43 12 4491,4552,4690,4749,4905,4957,5034,5099,5121,5185,5358,5403,	
refieren 2 43 2 6027,6325,	
72% 1 43 1 4489,	
67%* 1 43 1 4486,	
indetectable 2 43 2 4485,4686,	
copias/ml)c 2 43 2 4481,4682,	
79% 2 43 2 4961,5053,	
-4 2 43 2 4478,5672,	
04* 1 43 1 4477,	
-5 3 43 3 4474,4476,4677,	
86* 1 43 1 4473,	
-6 1 43 1 4472,	
Reducción 2 43 2 4467,4672,	
325 1 43 1 4465,	
355 1 43 1 4464,	
354 1 43 1 4463,	
15% 3 43 3 4458,4703,6298,	
12% 1 43 1 4457,	
8% 2 43 2 4455,4707,	
Empeoramiento 2 43 2 4450,4660,	
38% 1 43 1 4449,	
36% 2 43 2 4448,4487,	
35% 2 43 2 4447,6299,	
39% 3 43 3 4446,4950,5019,	
61% 1 43 1 4438,	
70%* 1 43 1 4437,	
62% 1 43 1 4436,	
72%* 1 43 1 4435,	
histológicab 2 43 2 4434,4648,	
Mejora 4 43 4 4433,4439,4647,4651,	
296 1 43 1 4432,	
314 2 43 2 4430,4431,	
n 4 43 4 4429,4462,4646,4669,	
022) 2 43 2 4417,4878,	
(log10 2 43 2 4480,4681,	
(ensayo 6 43 6 4416,4422,4575,4877,5071,5330,	
(LVD) 1 43 1 4410,	
compara 2 43 2 4407,5823,	
(ETV) 1 43 1 4405,	
aleatorizados 1 43 1 4398,	
e 2 43 2 4367,6438,	
características 1 43 1 4357,	
Independientemente 1 43 1 4354,	
positivo 1 43 1 4353,	
copias/ml) 5 43 5 4343,4553,4750,5500,5649,	
400 3 43 3 4342,5499,7933,	
(semana 1 43 1 4336,	
log10 6 43 6 4325,5648,5674,6129,6227,6413,	
DNA 2 43 2 4320,4338,	
pronunciada 1 43 1 4302,	
incluyó 1 43 1 5472,	
mejora 1 43 1 4299,	
130 1 43 1 6065,	
alta 2 43 2 4286,8045,	
Una 1 43 1 4283,	
39 1 43 1 4475,	
(todos 1 43 1 4276,	
comparable 1 43 1 4263,	
igual 1 43 1 4256,	
índice 6 43 6 4251,4441,4452,4653,4662,6875,	
empeoramiento 1 43 1 4234,	
preñadas 1 43 1 7672,	
Knodell 6 43 6 4227,4244,4255,4294,4533,4730,	
027) 2 43 2 4423,5072,	
necroinflamatoria 4 43 4 4225,4292,4531,4728,	
309 1 43 1 7067,	
puntos 1 43 1 4221,	
633 1 43 1 4196,	
comparador 1 43 1 4192,	
serológica 2 43 2 4180,4843,	
bioquímica 2 43 2 4178,4845,	
beneficio 1 43 1 4169,	
tasa 3 43 3 4158,4331,4944,	
gliomas 1 43 1 7852,	
menor 1 43 1 4157,	
mutada 1 43 1 4151,	
unión 2 43 2 4142,6741,	
secuenciadas 1 43 1 4132,	
000 1 43 1 4128,	
modesto 1 43 1 4104,	
monosustituciones 1 43 1 4087,	
741 1 43 1 4079,	
16 4 43 4 4077,7012,7318,8143,	
disminuyen 1 43 1 4071,	
V) 1 43 1 4070,	
rtM250I 1 43 1 4067,	
I; 1 43 1 4065,	
disminución 1 43 1 6685,	
S; 1 43 1 4060,	
L 2 43 2 4057,4068,	
I 1 43 1 4056,	
G 2 43 2 4055,4063,	
(rtT184A 1 43 1 4052,	
observadas 1 43 1 4047,	
susceptibilidad 1 43 1 4039,	
adicionales 2 43 2 4024,7619,	
Datos 1 43 1 7386,	
rtL180M 1 43 1 4004,	
rtM204V 1 43 1 4002,	
(LVDr) 1 43 1 3998,	
cepa 1 43 1 3989,	
emtricitabina 2 43 2 3981,5520,	
seis 1 43 1 3971,	
antagonizó 1 43 1 3962,	
amplio 1 43 1 3945,	
anti-VHB 1 43 1 3940,	
antagonizaron 1 43 1 3937,	
zidovudina 1 43 1 3935,	
estavudina 1 43 1 3932,	
didanosina 1 43 1 3930,	
funcionales 1 43 1 3923,	
grasas 1 43 1 6623,	
sensibilidad 4 43 4 3913,4017,4073,4107,	
M184V 2 43 2 3908,5763,	
altas 2 43 2 3895,7510,	
presión 1 43 1 3892,	
confirmando 1 43 1 3890,	
M184I 1 43 1 3889,	
seleccionaron 1 43 1 3886,	
cultivos 7 43 7 3880,3927,3967,3984,4043,4162,7740,	
estudio 6 43 6 3878,6071,6354,7549,7646,7662,	
virales 1 43 1 3874,	
títulos 1 43 1 3873,	
resultado 1 43 1 3849,	
dió 1 43 1 3847,	
experimentales 1 43 1 3846,	
condiciones 1 43 1 3845,	
tipos 2 43 2 3841,7847,	
VIH-1 1 43 1 3838,	
aislados 3 43 3 3835,4050,6166,	
cepas 1 43 1 3831,	
panel 1 43 1 3829,	
inhibitoria 2 43 2 3823,3893,	
sensibles 1 43 1 3815,	
siguen 1 43 1 3813,	
neumocitos 1 43 1 7804,	
rtN236T 1 43 1 3810,	
recombinantes 1 43 1 3801,	
059 1 43 1 3797,	
010 1 43 1 3794,	
(rango 1 43 1 3792,	
026 2 43 2 3790,3858,	
rtM204V) 1 43 1 3787,	
(rtL180M 1 43 1 3785,	
reversible 1 43 1 7403,	
LVDr 5 43 5 3784,4587,5954,6126,6409,	
mutantes 2 43 2 3779,3901,	
EC50 3 43 3 3771,3852,3868,	
75 2 43 2 6661,7320,	
silvestre 3 43 3 3767,3990,4085,	
transfectadas 1 43 1 3761,	
humanas 2 43 2 3760,6745,	
004 1 43 1 3755,	
concentración 1 43 1 3752,	
EC50) 1 43 1 3749,	
50% 1 43 1 3748,	
(reducción 1 43 1 3746,	
Actividad 1 43 1 3736,	
sanos; 1 43 1 6600,	
160 1 43 1 3734,	
Conservar 1 43 1 7963,	
(Ki 1 43 1 3732,	
HepG2 2 43 2 3731,3759,	
células 5 43 5 3730,3758,3843,7714,7719,	
mitocondrial 1 43 1 3728,	
(1%) 1 43 1 6310,	
relevantes 1 43 1 3718,	
313 1 43 1 4466,	
Además 1 43 1 3708,	
µM 3 43 3 3707,3756,3791,	
ADN-polimerasas 1 43 1 3695,	
débil 1 43 1 3692,	
M 2 43 2 3686,4058,	
0012 1 43 1 3685,	
ADN- 1 43 1 3678,	
Ki 2 43 2 3673,3702,	
síntesis 3 43 3 3663,3725,3741,	
(3) 1 43 1 3662,	
pregenómico 1 43 1 3660,	
mensajero 1 43 1 3659,	
puntuación 2 43 2 4240,4284,	
ARN 2 43 2 3658,5737,	
partir 1 43 1 3656,	
(-) 1 43 1 3652,	
cadena 2 43 2 3651,3666,	
transcripción 1 43 1 3647,	
(2) 1 43 1 3646,	
grasas) 2 43 2 6630,6641,	
(priming) 1 43 1 3640,	
cebado 1 43 1 3639,	
(1) 1 43 1 3638,	
funcionalmente 1 43 1 3630,	
entecavir-TP 2 43 2 3628,3675,	
desoxiguanosina-TP 1 43 1 3627,	
natural 1 43 1 3626,	
Al 3 43 3 3621,4987,5525,	
intracelular 1 43 1 3617,	
semivida 3 43 3 3616,6865,6892,	
(TP) 1 43 1 3611,	
trifosfato 1 43 1 3610,	
efizcamente 1 43 1 3605,	
fosforila 1 43 1 3604,	
acción 1 43 1 3587,	
Mecanismo 1 43 1 3585,	
filtración 1 43 1 6842,	
J05AF10 1 43 1 3584,	
ATC 1 43 1 3583,	
Código 1 43 1 3582,	
inversa 5 43 5 3581,3648,3977,4008,4148,	
transcriptasa 4 43 4 3580,3976,4007,4147,	
inhibidores 2 43 2 3577,3972,	
nucleótidos 1 43 1 3576,	
primaria 2 43 2 4540,4737,	
farmacoterapéutico 1 43 1 3573,	
Grupo 2 43 2 3572,7338,	
farmacodinámicas 1 43 1 3571,	
conservar 2 43 2 7957,7970,	
Propiedades 2 43 2 3570,6451,	
	5 1 43 1 3568,	
ESTE 1 43 1 3566,	
FARMACOLÓGICAS 1 43 1 3564,	
PROPIEDADES 1 43 1 3563,	
estándar 2 43 2 3560,6620,	
soporte 1 43 1 3559,	
crónica) 1 43 1 6986,	
recurrir 1 43 1 3554,	
fuera 1 43 1 3552,	
hubiera 1 43 1 3547,	
producirse 1 43 1 3538,	
inesperadas 1 43 1 3534,	
40 4 43 4 3528,3706,7050,7242,	
únicas 1 43 1 3525,	
Periodo 1 43 1 7944,	
14 3 43 3 3521,6311,7383,	
tasas 3 43 3 4893,5087,5346,	
períodos 2 43 2 3518,7491,	
20 4 43 4 3515,5673,6054,7240,	
sanos 2 43 2 3511,7127,	
voluntarios 3 43 3 3510,6599,7126,	
sobredosis 2 43 2 3508,3540,	
ningún 1 43 1 3505,	
9 8 43 8 3499,4323,4461,7028,7036,7047,8025,8144,	
subcutáneo 1 43 1 3497,	
tejido 1 43 1 3496,	
piel 1 43 1 3493,	
rash 1 43 1 3489,	
conocida 1 43 1 3488,	
aprobación 1 43 1 3485,	
siguientes 2 43 2 3474,7704,	
identificado 1 43 1 3472,	
identificadas 1 43 1 3465,	
además 1 43 1 3457,	
años) 2 43 2 3404,5458,	
65 4 43 4 3403,5457,5640,7216,	
clínicos) 2 43 2 3394,5446,	
respecto 4 43 4 3384,3986,4082,4228,	
aparentes 2 43 2 3375,5429,	
hubo 4 43 4 3373,5427,7189,7497,	
Sexo/edad 1 43 1 3371,	
similar 1 43 1 3354,	
incluían 1 43 1 3351,	
corporal 3 43 3 6738,7187,7291,	
actividad) 1 43 1 3349,	
Naturaleza 1 43 1 7983,	
(tratamiento 1 43 1 3345,	
regímenes 3 43 3 3342,5516,5776,	
podría 2 43 2 3315,6713,	
independientemente 1 43 1 3300,	
interrumpe 1 43 1 3299,	
perfectamente 1 43 1 7979,	
priori 1 43 1 3294,	
definida 1 43 1 3292,	
interrumpió 2 43 2 3285,4762,	
hizo 1 43 1 3249,	
les 2 43 2 3248,4863,	
limitado 2 43 2 3241,3334,	
número 3 43 3 3240,3333,5314,	
sólo 4 43 4 3238,4101,5941,7364,	
notificaron 1 43 1 3223,	
24/28) 1 43 1 3221,	
(86% 1 43 1 3220,	
tratamiento]) 1 43 1 3180,	
final 6 43 6 3178,5190,5203,5422,6151,6434,	
medición 1 43 1 3176,	
última 1 43 1 3175,	
basal 7 43 7 3169,4285,4524,4527,4721,4724,6164,	
[nivel 1 43 1 3168,	
referencia 1 43 1 3167,	
10% 2 43 2 3143,4456,	
Sobredosis 1 43 1 3500,	
6% 2 43 2 3134,6297,	
recibido 1 43 1 3128,	
incluido 1 43 1 3112,	
interrumpido 1 43 1 3102,	
agudas 1 43 1 3095,	
monitorización 3 43 3 3076,5983,6281,	
coincidió 1 43 1 3066,	
viral 5 43 5 3059,3637,4471,4676,5631,	
carga 4 43 4 3058,4470,4675,5630,	
vertebrales 1 43 1 7601,	
continuaban 1 43 1 3040,	
resolvieron 1 43 1 3038,	
semanas; 1 43 1 3034,	
comienzo 2 43 2 3020,3203,	
recibían 1 43 1 5709,	
medio 2 43 2 3017,5552,	
frente 14 43 14 2955,3000,3826,3954,4190,4515,4712,5060,5112,5215,5266,5295,5641,6658,	
produjeron 2 43 2 2930,2975,	
3x 1 43 1 2808,	
4% 2 43 2 2801,2957,	
envases 1 43 1 8076,	
relacionados 2 43 2 2705,2909,	
aspectos 2 43 2 2704,2908,	
nuevos 2 43 2 2703,2907,	
distribución 1 43 1 6731,	
reveló 2 43 2 2702,2906,	
crónico 2 43 2 2691,2895,	
48 12 43 12 2687,2891,4183,4337,4393,4641,4680,4755,4775,5308,5669,6348,	
monoinfección 1 43 1 3364,	
000/mm3 2 43 2 2675,2879,	
plaquetas 2 43 2 2672,2876,	
038 1 43 1 5471,	
recuento 4 43 4 2670,2874,5551,5564,	
11% 4 43 4 2667,3002,3253,4666,	
amilasa 2 43 2 2643,2847,	
494 1 43 1 5556,	
(Límite 2 43 2 4547,4744,	
presenta 1 43 1 4155,	
g/dl 1 43 1 2634,	
albúmina 1 43 1 2630,	
90%* 1 43 1 4488,	
observaron 11 43 11 2627,2844,3870,5943,6156,6773,7513,7543,7654,7696,7768,	
LSN 8 43 8 2618,2790,2836,2939,2984,3159,4317,4815,	
146 1 43 1 6279,	
superiores 1 43 1 2606,	
Business 1 43 1 8123,	
valores 6 43 6 2600,3699,3850,3864,6506,6549,	
1% 7 43 7 2596,2637,2678,2815,2882,4688,5927,	
asoció 1 43 1 4296,	
inicial 12 43 12 2593,2608,2625,2649,2664,2811,2827,2842,2853,2868,2945,2990,	
elevaciones 2 43 2 2585,3310,	
5% 5 43 5 2583,3399,5452,6005,7299,	
(LSN) 1 43 1 2568,	
normal 3 43 3 2567,6924,7131,	
rango 7 43 7 2566,3855,3946,6519,7212,7236,7314,	
superior 5 43 5 2564,2685,2889,7960,7973,	
límite 1 43 1 2563,	
> 26 43 26 2559,2573,2588,2603,2614,2620,2644,2659,2787,2792,2807,2822,2833,2838,2848,2863,2935,2941,2980,2986,3161,3402,3733,3860,4810,5456,	
Incompatibilidades 1 43 1 7939,	
2% 10 43 10 2550,2652,2778,2856,2948,2993,4923,4975,6003,6007,	
(con 1 43 1 7432,	
Desviaciones 2 43 2 2540,2768,	
3er 2 43 2 6024,6322,	
significativamente 3 43 3 5635,7332,7354,	
supresión 1 43 1 4789,	
psiquiátricos 2 43 2 2539,2767,	
parámetro 2 43 2 7328,7351,	
insomnio 2 43 2 2537,2765,	
lugar 3 43 3 2532,2760,6643,	
alteraciones 2 43 2 2529,2757,	
gastrointestinales 2 43 2 2525,2753,	
dispepsia 2 43 2 2523,2751,	
diarrea 2 43 2 2521,2749,	
nervioso 3 43 3 2518,2746,7407,	
Trastornos 9 43 9 2515,2524,2526,2538,2743,2752,2754,2766,3490,	
53 2 43 2 2509,4479,	
global 1 43 1 4267,	
exposición 7 43 7 2493,2723,3710,7094,7124,7141,7682,	
25% 2 43 2 3388,5440,	
HBeAg) 1 43 1 2484,	
(positivos 1 43 1 2480,	
Experiencia 7 43 7 2472,2709,3319,3455,4164,4371,4554,	
intervalo 1 43 1 2469,	
decreciente 1 43 1 2463,	
orden 1 43 1 2462,	
1/100 1 43 1 2453,	
solapamiento 1 43 1 4615,	
1/10); 1 43 1 2450,	
micromolares 2 43 2 3883,3960,	
( 11 43 11 2449,2452,3387,3398,4499,4698,5197,5412,5439,5451,7788,	
frecuente 8 43 8 2448,2451,2511,2519,2536,2741,2747,2764,	
definen 1 43 1 2445,	
órganos 1 43 1 2439,	
clasificación 1 43 1 2437,	
sistema 5 43 5 2435,2517,2745,6760,7406,	
enumeran 2 43 2 2432,2460,	
(3%) 1 43 1 2416,	
(4%) 1 43 1 2413,	
mareos 2 43 2 2412,2513,	
(6%) 2 43 2 2411,6286,	
(9%) 1 43 1 2409,	
cefalea 3 43 3 2408,2512,2742,	
relacionadas 2 43 2 2404,2425,	
posiblemente 2 43 2 2403,2424,	
consideradas 2 43 2 2399,2420,	
gravedad 2 43 2 2397,2465,	
año 6 43 6 4781,6025,6323,6447,7466,7552,	
comparables 1 43 1 2389,	
resultados 8 43 8 2382,2543,2771,4273,4390,4638,6022,6320,	
desviaciones 1 43 1 2379,	
incluidas 1 43 1 2377,	
perfiles 1 43 1 2370,	
ciego 4 43 4 2365,4400,4565,4852,	
periodo 3 43 3 2357,5609,6939,	
183) 1 43 1 2349,	
679) 1 43 1 2343,	
Park 1 43 1 8124,	
= 16 43 16 2342,2348,2353,4551,4617,4630,4748,4890,4941,5046,5084,5140,5343,5596,5601,7118,	
(n 13 43 13 2341,2347,2352,4616,4629,4889,4940,5083,5139,5342,5595,5600,7117,	
mg/día 3 43 3 2340,2346,3516,	
recibieron 2 43 2 2334,3513,	
720 1 43 1 2328,	
total 4 43 4 2325,2613,2832,6739,	
cuatro 1 43 1 2318,	
evaluación 1 43 1 2310,	
Reacciones 1 43 1 2307,	
8 9 43 9 2306,3896,4013,5546,6582,6637,7002,7038,8132,	
alterar 1 43 1 2297,	
somnolencia 2 43 2 2290,2514,	
fatiga 2 43 2 2288,2410,	
hámster 1 43 1 7722,	
Mareos 1 43 1 2287,	
tenga 1 43 1 2282,	
espera 1 43 1 2280,	
farmacodinámico 1 43 1 2275,	
perfil 6 43 6 2274,2486,2716,3326,3356,3378,	
Basándose 2 43 2 2271,6477,	
realizado 2 43 2 2256,5880,	
máquinas 3 43 3 2252,2270,2304,	
55%* 1 43 1 4649,	
capacidad 3 43 3 2247,2265,2299,	
Efectos 1 43 1 2244,	
excreción 3 43 3 2225,6480,7688,	
materna 2 43 2 2215,2231,	
leche 3 43 3 2214,2230,7693,	
excreta 1 43 1 2211,	
neonato 1 43 1 2202,	
(-3 1 43 1 5639,	
contenían 1 43 1 3905,	
impedir 1 43 1 2198,	
apropiadas 1 43 1 2196,	
recurrirse 1 43 1 2192,	
nacido 1 43 1 2187,	
biodisponibilidad 2 43 2 6471,6490,	
terapia 4 43 4 3306,3557,6047,6330,	
recién 1 43 1 2186,	
madre 1 43 1 2184,	
eficaces 1 43 1 2168,	
anticonceptivos 1 43 1 2167,	
métodos 1 43 1 2166,	
utilizar 4 43 4 2165,2251,2269,2303,	
fértil 1 43 1 2163,	
feto 1 43 1 2158,	
desarrollo 3 43 3 2156,5793,7795,	
riesgos 1 43 1 2152,	
suspender 1 43 1 3088,	
conocen 1 43 1 2150,	
claramente 1 43 1 2144,	
embarazo 1 43 1 2140,	
humanos 9 43 9 2133,2217,7431,7474,7540,7582,7743,7783,7902,	
seres 1 43 1 2132,	
potencial 1 43 1 2130,	
elevadas 5 43 5 2121,7588,7625,7748,7879,	
reproductiva 1 43 1 2118,	
toxicidad 7 43 7 2117,3550,7442,7591,7593,7628,7648,	
mostrado 1 43 1 2116,	
estudios 10 43 10 2112,2219,2257,3922,3950,7391,7447,7476,7523,7705,	
18% 2 43 2 2871,4511,	
utilización 2 43 2 2105,3479,	
suficientes 2 43 2 2102,7378,	
lactancia 2 43 2 2098,2236,	
Embarazo 1 43 1 2096,	
CYP450 2 43 2 2093,6762,	
mediadas 1 43 1 2091,	
(> 2 43 2 3155,4287,	
medicamentosas 1 43 1 2090,	
produzcan 1 43 1 2088,	
improbable 1 43 1 2083,	
(CYP450) 1 43 1 2075,	
P450 1 43 1 2074,	
citocromo 1 43 1 2073,	
enzimas 1 43 1 2071,	
precedió 1 43 1 3063,	
inhibidor 4 43 4 2068,3691,4144,6756,	
inductor 2 43 2 2066,6758,	
sustrato 3 43 3 2065,3625,6755,	
(hioides) 1 43 1 7633,	
abacavir 1 43 1 3929,	
actúa 2 43 2 2063,6753,	
ambas 1 43 1 6603,	
farmacocinéticas 2 43 2 2053,6452,	
interacciones 2 43 2 2052,2089,	
(1 1 43 1 6651,	
posibles 1 43 1 2045,	
estrechamente 1 43 1 2039,	
vigilarse 2 43 2 2038,3542,	
tipo 2 43 2 2034,3766,	
coadministra 1 43 1 2031,	
Si 2 43 2 2028,3295,	
excretan 1 43 1 2017,	
efectos 5 43 5 2007,2260,3716,7571,7655,	
disoproxil 2 43 2 2000,5523,	
1x 1 43 1 5413,	
tenofovir 4 43 4 1999,2060,3933,5522,	
dipivoxil 1 43 1 1997,	
adefovir 4 43 4 1996,2058,3809,5832,	
excepción 1 43 1 1993,	
A 5 43 5 1992,4853,5306,5622,7114,	
séricas 2 43 2 1986,6744,	
tubular 2 43 2 1980,6846,	
secreción 2 43 2 1979,6845,	
ensayo 7 43 7 4562,4599,5242,5280,5470,5528,5812,	
compiten 1 43 1 1976,	
negativamente 1 43 1 1969,	
afectan 2 43 2 1968,2023,	
coadministración 2 43 2 1964,2010,	
riñón 2 43 2 1958,6799,	
predominantemente 2 43 2 1955,6796,	
elimina 2 43 2 1954,6795,	
Dado 2 43 2 1950,2146,	
interacción 2 43 2 1949,3925,	
formas 2 43 2 1947,6604,	
histológica 4 43 4 4176,4213,4300,4368,	
medicamentos 6 43 6 1944,1966,1991,2014,2036,9726,	
M; 1 43 1 3862,	
Interacción 1 43 1 1940,	
encuentra 1 43 1 1929,	
incorporación 1 43 1 4021,	
personas 1 43 1 1927,	
glucosa-galactosa 1 43 1 1919,	
malabsorción 1 43 1 1917,	
Lapp 1 43 1 1915,	
89% 1 43 1 5105,	
lactasa 1 43 1 1913,	
deficiencia 1 43 1 1911,	
galactosa 1 43 1 1910,	
intolerancia 1 43 1 1907,	
raros 1 43 1 1905,	
microcristalina 1 43 1 7924,	
hereditarios 1 43 1 1904,	
9) 1 43 1 7119,	
problemas 1 43 1 1903,	
Lactosa 2 43 2 1883,7918,	
2x 5 43 5 2793,2834,2839,2942,2987,	
oportunas 1 43 1 1882,	
medidas 5 43 5 1879,2195,4271,6147,6430,	
tomando 1 43 1 1877,	
seguir 1 43 1 1876,	
transmisión 2 43 2 1867,2179,	
especial 1 43 1 8084,	
positivos) 1 43 1 4807,	
reduzca 1 43 1 1863,	
demostrado 2 43 2 1857,2223,	
advertirse 1 43 1 1849,	
generales 3 43 3 1847,2527,2755,	
Aspectos 1 43 1 1846,	
células/mm3) 2 43 2 1845,5569,	
200 2 43 2 1844,5568,	
celulares 8 43 8 1841,3697,3881,3928,3968,3985,4044,4163,	
recuentos 1 43 1 1840,	
bajos 2 43 2 1839,3866,	
limitada 1 43 1 1831,	
dispone 2 43 2 1812,1828,	
No 14 43 14 1810,2048,2099,2169,2232,2253,3501,5426,6993,7541,7694,7940,7956,7969,	
régimen 5 43 5 1802,2363,4851,5510,5575,	
bioequivalencia 1 43 1 6597,	
coinfección 2 43 2 1795,5463,	
68 1 43 1 1792,	
µM) 2 43 2 3735,3798,	
estudiado 2 43 2 1762,1790,	
Entecavir 6 43 6 1758,2061,3687,5960,6259,7736,	
TARGA 9 43 9 1757,1803,3344,5468,5511,5517,5711,5752,5777,	
estén 2 43 2 1755,8071,	
3) 1 43 1 2125,	
utilizarse 3 43 3 1746,2137,5786,	
96 8 43 8 2699,2903,4887,5006,5081,5161,5340,5392,	
(TARGA) 1 43 1 1736,	
1/10) 1 43 1 2455,	
actividad 6 43 6 1735,3596,3822,3939,3952,3964,	
gran 2 43 2 1734,3348,	
utilizó 1 43 1 1713,	
observado 5 43 5 1704,2051,4114,5758,6880,	
efectivo 2 43 2 1698,5727,	
test 2 43 2 7706,7724,	
estaban 5 43 5 1694,1729,1799,5723,5746,	
evaluado 3 43 3 1686,2005,5716,	
antirretroviral 4 43 4 1681,1732,1786,3346,	
313) 1 43 1 5141,	
simultáneamente 6 43 6 1679,1696,1784,5467,5710,5725,	
2006 1 43 1 8157,	
recibiendo 8 43 8 1678,1695,1730,1756,1783,1800,5724,5747,	
VIH/VHB 10 43 10 1674,1691,1752,1780,1797,3339,5464,5706,5720,5744,	
coinfectados 12 43 12 1672,1689,1750,1778,1824,1834,3322,3337,5483,5704,5719,5742,	
infectados 2 43 2 1661,7104,	
27 1 43 1 7027,	
co- 1 43 1 1660,	
existen 2 43 2 1651,2100,	
D 2 43 2 1649,1670,	
C 4 43 4 1647,1668,4053,4062,	
Coinfección 1 43 1 1644,	
(945 1 43 1 6624,	
tacrolimus 2 43 2 1639,7116,	
acumulada 4 43 4 4896,4947,5090,5349,	
ciclosporina 2 43 2 1637,7113,	
minuciosamente 1 43 1 1620,	
presentan 3 43 3 4009,4388,4636,	
evaluarse 1 43 1 1619,	
receptores 3 43 3 1610,1630,7099,	
hay 2 43 2 1597,2170,	
69 3 43 3 2738,7031,7224,	
hepático 5 43 5 1596,1614,1634,7092,7103,	
trasplante 4 43 4 1595,1613,1633,7102,	
Blister 1 43 1 8139,	
esclarecido 1 43 1 1587,	
plazo 1 43 1 1580,	
(+) 1 43 1 3667,	
clínica 3 43 3 1577,4165,5840,	
importancia 1 43 1 1576,	
apareció 1 43 1 1563,	
presente 2 43 2 1555,9714,	
rtM250 5 43 5 1552,4031,4094,5923,9711,	
emergente 4 43 4 6019,6238,6317,6440,	
rtS202 6 43 6 1550,4029,4061,4092,5921,9709,	
derivada 2 43 2 1543,9702,	
previamente 4 43 4 1535,4307,4348,9694,	
respuestas 2 43 2 4175,4365,	
pequeño 2 43 2 1528,9687,	
envase 4 43 4 7966,7987,7989,8064,	
porcentaje 2 43 2 1527,9686,	
detectar 3 43 3 1523,2044,9682,	
tratar 1 43 1 1715,	
análisis 5 43 5 1520,3819,7306,7341,9679,	
realizarse 2 43 2 1519,9678,	
población 2 43 2 1503,9662,	
(ETVr) 7 43 7 1500,1542,5918,6161,6260,9659,9701,	
asociadas 2 43 2 1494,9653,	
doble 4 43 4 2364,4399,4564,6547,	
incluyendo 2 43 2 1492,9651,	
secundarias 2 43 2 1491,9650,	
(cirrosis) 1 43 1 4259,	
posterior 3 43 3 1487,5897,9646,	
conducir 5 43 5 1484,2249,2267,2301,9643,	
podrían 3 43 3 1483,2296,9642,	
Metabolismo 1 43 1 6750,	
sustituciones 14 43 14 1477,1490,1545,4001,4046,4118,5912,5940,5948,6157,6197,9636,9649,9704,	
codifican 2 43 2 1476,9635,	
polimerasa 7 43 7 1471,3600,3636,3643,3679,3721,9630,	
específica 2 43 2 1461,9620,	
analíticos 2 43 2 1452,9611,	
marcadores 2 43 2 1451,9610,	
mejoría 3 43 3 1448,4212,9607,	
cambios 5 43 5 1440,4023,7514,7544,9599,	
(INTIs) 1 43 1 3978,	
asegurarse 2 43 2 1436,9595,	
médicos 2 43 2 1434,9593,	
potencialmente 2 43 2 1427,9586,	
diferenciar 2 43 2 1414,9573,	
riguroso 2 43 2 1412,9571,	
F 1 43 1 4054,	
Estos 2 43 2 1407,9566,	
factores 2 43 2 1400,9559,	
u 2 43 2 1398,9557,	
obesas) 2 43 2 1394,9553,	
mujeres 9 43 9 1393,2109,2160,3390,5442,7159,7223,7247,9552,	
aminoácidos 1 43 1 4027,	
VIH 16 43 16 1701,1708,1726,1769,1826,1836,3324,3903,3956,5485,5494,5497,5730,5739,5765,5797,	
particular 2 43 2 1391,9550,	
prescriben 2 43 2 1382,9541,	
precaución 5 43 5 1379,1460,1881,9538,9619,	
actuarse 2 43 2 1377,9536,	
ofreció 1 43 1 4864,	
sérico 2 43 2 1375,9534,	
lactato 2 43 2 1374,9533,	
rtT184 5 43 5 1549,4028,4091,5920,9708,	
hepático/esteatosis 2 43 2 1367,9526,	
fallo 4 43 4 1366,1369,9525,9528,	
pancreatitis 2 43 2 1365,9524,	
asociaron 4 43 4 1363,3052,4328,9522,	
desenlace 2 43 2 1360,9519,	
veces 23 43 23 1358,2561,2575,2590,2605,2616,2622,2646,2661,3157,3163,4014,4080,4813,6883,7122,7425,7470,7536,7578,7779,7790,9517,	
indicar 2 43 2 1348,9507,	
abdominal 2 43 2 1346,9505,	
dolor 2 43 2 1345,9504,	
embriotoxicidad 1 43 1 7569,	
vómitos 4 43 4 1343,2520,2748,9502,	
vasculares 1 43 1 7863,	
benignos 3 43 3 1339,7864,9498,	
digestivos 2 43 2 1338,9497,	
etiología 2 43 2 1334,9493,	
metabólica/láctica 2 43 2 1332,9491,	
progresiva 2 43 2 1329,9488,	
log10/ml 1 43 1 3061,	
transaminasas 4 43 4 1327,1419,9486,9578,	
rápida 2 43 2 1324,9483,	
CD4 3 43 3 1842,5554,5566,	
observa 3 43 3 1321,6497,9480,	
Debe 4 43 4 1311,1376,9470,9535,	
descartarse 2 43 2 1308,9467,	
Como 2 43 2 1299,9458,	
análogos 6 43 6 1296,1316,1383,9455,9475,9542,	
78%* 1 43 1 4505,	
mortal 4 43 4 1283,1361,9442,9520,	
hipoxemia) 2 43 2 1280,9439,	
acidosis 8 43 8 1275,1331,1352,1431,9434,9490,9511,9590,	
grave 5 43 5 1267,1288,6913,9426,9447,	
hepatomegalia 8 43 8 1266,1287,1328,1396,9425,9446,9487,9555,	
administraba 1 43 1 7564,	
láctica 8 43 8 1264,1276,1353,1432,9423,9435,9512,9591,	
Acidosis 2 43 2 1263,9422,	
(379 1 43 1 6635,	
51) 1 43 1 5597,	
frecuencia 5 43 5 1262,2471,3486,6206,9421,	
PRIMERA 1 43 1 8148,	
apropiados 4 43 4 1259,1521,9418,9680,	
controles 2 43 2 1258,9417,	
someterse 2 43 2 1255,9414,	
peso 5 43 5 7173,7186,7278,7290,7598,	
finalizado 2 43 2 1251,9410,	
nucleósido 3 43 3 1305,3591,9464,	
síntomas 4 43 4 1241,1337,9400,9496,	
presenten 2 43 2 1240,9399,	
interrumpa 2 43 2 1224,9383,	
funciones 2 43 2 1207,9366,	
asociados 4 43 4 1201,1284,9360,9443,	
serológicos 2 43 2 1200,9359,	
virológicos 2 43 2 1198,9357,	
parámetros 3 43 3 1196,6904,9355,	
regularmente 2 43 2 1194,9353,	
controlarse 2 43 2 1193,9352,	
inicio 13 43 13 1182,1557,2579,2797,3172,3450,4230,4261,4589,5526,6991,9341,9716,	
7 9 43 9 1180,2243,3318,3448,4798,7034,7076,8111,9339,	
Child-Pugh 3 43 3 1179,3447,9338,	
Lista 1 43 1 7911,	
escala 8 43 8 1178,3446,4224,4237,4291,4530,4727,9337,	
valoración 3 43 3 1175,3443,9334,	
repetidas 3 43 3 7396,7450,7528,	
tenían 5 43 5 1173,4279,5488,5562,9332,	
observación 3 43 3 1166,3435,9325,	
absorbe 1 43 1 6456,	
comparación 3 43 3 1157,3426,9316,	
hepáticas 3 43 3 1154,3423,9313,	
adversas 13 43 13 1153,2047,2293,2308,2314,2392,2419,2458,3422,3461,3476,3533,9312,	
reacciones 12 43 12 1152,2046,2292,2313,2391,2418,2457,3421,3460,3475,3532,9311,	
elevada 4 43 4 1150,3419,3711,9309,	
incidencia 7 43 7 1148,3308,3417,7639,7772,7844,9307,	
Hipromelosa 1 43 1 7931,	
observó 10 43 10 1146,3415,7400,7445,7568,7590,7627,7812,7841,9305,	
descompensada 10 43 10 1139,1144,1191,3408,3413,5806,5821,9298,9303,9350,	
resistencias 3 43 3 1524,5795,9683,	
justificada 2 43 2 1135,9294,	
reanudación 2 43 2 1126,9285,	
determinados 2 43 2 1123,9282,	
interrumpir 2 43 2 1115,9274,	
meses 4 43 4 1112,1232,9271,9391,	
mínimo 4 43 4 1109,3170,6647,9268,	
laboratorio 6 43 6 1106,2387,2548,2776,3833,9265,	
clínico 4 43 4 1101,4170,7757,9260,	
seguimiento 10 43 10 1100,1411,3183,3236,3251,3274,5250,5311,9259,9570,	
mediante 2 43 2 1098,9257,	
periódicos 2 43 2 1097,9256,	
monitorizarse 4 43 4 1094,1511,9253,9670,	
notificó 2 43 2 1081,9240,	
24 12 43 12 1075,3213,4827,5253,5604,5612,5624,5895,6094,6377,6899,9234,	
23 3 43 3 1073,3211,9232,	
prueba 1 43 1 8053,	
adversos 2 43 2 3717,7656,	
relacionado 2 43 2 1428,9587,	
media 10 43 10 1062,2507,2697,2736,2901,3769,5543,7221,7245,9221,	
letales 2 43 2 1048,9207,	
graves 7 43 7 1046,1155,1356,3424,9205,9314,9515,	
casos 11 43 11 1043,1124,1273,1355,3050,5755,5789,9202,9283,9432,9514,	
notificado 7 43 7 1042,1272,3093,3504,5733,9201,9431,	
Leve 1 43 1 6995,	
embargo 4 43 4 1039,7361,7881,9198,	
Sin 5 43 5 1038,4424,7360,7880,9197,	
espontáneamente 2 43 2 1037,9196,	
remitir 2 43 2 1036,9195,	
parece 2 43 2 1035,9194,	
mayoría 7 43 7 1034,1079,3047,3217,4360,9193,9238,	
elevación 4 43 4 1024,1323,9183,9482,	
normalmente 4 43 4 1021,1285,9180,9444,	
asocian 4 43 4 1020,1445,9179,9604,	
potenciales 1 43 1 2153,	
post-tratamiento 9 43 9 1018,1070,3184,3275,3314,5251,5312,9177,9229,	
presentaban 2 43 2 5502,5549,	
Las 8 43 8 1016,2390,2417,2442,2456,4045,4086,9175,	
suspendido 2 43 2 1009,9168,	
comunicado 2 43 2 999,9158,	
distribuido 2 43 2 7998,8023,	
dichas 1 43 1 6196,	
También 2 43 2 996,9155,	
supervisión 2 43 2 992,9151,	
estrecha 2 43 2 991,9150,	
deben 13 43 13 988,1192,1254,1435,1518,1875,1921,2164,9147,9351,9413,9594,9677,	
consiguiente 4 43 4 987,2081,6602,9146,	
Agencia 1 43 1 8179,	
reagudización 4 43 4 981,1001,9140,9160,	
postcomercialización 1 43 1 3456,	
riesgo 8 43 8 975,1310,1402,1865,2129,9134,9469,9561,	
mayor 11 43 11 974,1261,3317,4335,5636,7157,7260,7300,7843,9133,9420,	
cirrosis 10 43 10 970,1138,1143,1190,3407,3412,9129,9297,9302,9349,	
asignados 2 43 2 5581,5654,	
descompensación 4 43 4 965,977,9124,9136,	
rtA181V 1 43 1 3812,	
embarazadas 1 43 1 2110,	
bilirrubina 4 43 4 961,2612,2831,9120,	
perros 3 43 3 7398,7532,7815,	
concentraciones 15 43 15 958,1985,2628,2641,2656,2845,2860,3882,3897,3948,3959,6459,6855,7745,9117,	
frecuencias 2 43 2 2441,2443,	
aumento 11 43 11 955,1372,1416,3022,3069,3205,7138,7636,9114,9531,9575,	
acompañados 2 43 2 952,9111,	
general 5 43 5 951,1509,3036,9110,9668,	
semanas 31 43 31 934,1076,1574,2361,2510,2688,2700,2739,2892,2904,3214,4184,4394,4642,4756,4828,4888,5082,5254,5309,5341,5605,5613,5625,5670,5936,6055,6338,7495,9093,9235,	
aparición 10 43 10 923,1067,1350,1488,1706,7613,9082,9226,9509,9647,	
descenso 4 43 4 4011,4218,6666,6676,	
mediana 5 43 5 918,3198,6052,6335,9077,	
definió 1 43 1 4215,	
habían 3 43 3 1532,5534,9691,	
tratados 40 43 40 914,1052,1534,1635,2952,2961,2997,3006,3012,3138,3147,3188,3257,3264,3340,4306,4347,4592,4937,5014,5024,5057,5065,5136,5146,5152,5167,5175,5212,5220,5531,5619,5853,5931,5977,6175,6275,9073,9211,9693,	
séricos 2 43 2 902,9061,	
aumentar 3 43 3 894,1983,9053,	
antiviral 6 43 6 889,1214,3737,3953,9048,9373,	
iniciar 2 43 2 886,9045,	
Después 5 43 5 884,6848,7174,7279,9043,	
ALT 35 43 35 882,891,945,1443,2558,2587,2602,2786,2806,2820,2934,2979,3025,3072,3154,3208,3271,3313,4314,4498,4697,4809,4915,4967,5041,5111,5133,5194,5368,5409,5681,9041,9050,9104,9602,	
mg) 1 43 1 7793,	
transitorios 2 43 2 877,9036,	
caracterizan 2 43 2 874,9033,	
rica 1 43 1 6621,	
frecuentes 4 43 4 871,2294,2394,9030,	
relativamente 2 43 2 870,9029,	
son 4 43 4 869,2291,6565,9028,	
reagudizaciones 11 43 11 862,925,1017,1045,1069,3094,9021,9084,9176,9204,9228,	
Reagudizaciones 4 43 4 857,2913,3085,9016,	
conteniendo 1 43 1 1804,	
especiales 5 43 5 802,5460,7952,8080,8961,	
precauciones 2 43 2 801,8960,	
Advertencias 2 43 2 799,8958,	
activo 3 43 3 790,4193,8949,	
principio 2 43 2 789,8948,	
68% 1 43 1 5062,	
Hipersensibilidad 2 43 2 787,8946,	
Contraindicaciones 2 43 2 786,8945,	
insuficiencia 8 43 8 782,811,1243,6909,7133,8941,8970,9402,	
residuos 3 43 3 1548,4090,9707,	
** 2 43 2 758,8917,	
* 2 43 2 746,8905,	
72 2 43 2 744,8903,	
aumentos 12 43 12 876,942,2555,2783,2803,2931,2976,3151,3268,7769,9035,9101,	
días 6 43 6 739,761,3522,6534,8898,8920,	
linfocitos 1 43 1 7742,	
diferencias 7 43 7 3374,5428,7166,7178,7190,7271,7283,	
5-7 2 43 2 738,8897,	
DPAC** 2 43 2 733,8892,	
ó 6 43 6 731,732,5045,5868,8890,8891,	
Hemodiálisis 2 43 2 729,8888,	
detallada 1 43 1 8167,	
Cmín 1 43 1 6553,	
05 4 43 4 716,4519,4716,8875,	
PCR 15 43 15 4546,4743,4908,4960,5037,5102,5124,5188,5361,5406,5887,6083,6143,6366,6427,	
10 18 43 18 714,2560,2788,2936,2981,3156,3861,5833,6219,6533,7004,7006,7424,7677,8010,8035,8158,8873,	
15 6 43 6 700,3619,6289,7008,7010,8859,	
día* 10 43 10 690,705,712,721,728,8849,8864,8871,8880,8887,	
25 4 43 4 685,4812,7252,8844,	
30-49 2 43 2 683,8842,	
(ml/min) 5 43 5 666,6992,7054,7077,8825,	
Resistencia 8 43 8 662,1458,3982,5839,5958,6257,8821,9617,	
Aclaramiento 3 43 3 656,6987,8815,	
Baraclude* 2 43 2 655,8814,	
rigurosamente 6 43 6 652,856,1513,8811,9015,9672,	
monitorizada 4 43 4 651,855,8810,9014,	
respuesta 26 43 26 647,851,1213,1423,1515,3291,3303,4246,4266,4333,4769,4787,4839,4860,4895,4946,5089,5231,5237,5322,5348,8806,9010,9372,9582,9674,	
sustitución 2 43 2 3888,3907,	
Por 8 43 8 643,847,1741,2080,2188,5780,8802,9006,	
ligera 1 43 1 6634,	
clínicamente 5 43 5 642,846,6700,8801,9005,	
evaluadas 4 43 4 641,845,8800,9004,	
sometidas 1 43 1 7585,	
desconocida 2 43 2 1335,9494,	
sido 10 43 10 640,844,1533,1685,1761,1789,5715,8799,9003,9692,	
falanges) 1 43 1 7611,	
sugiere 2 43 2 6837,6890,	
10) 1 43 1 4288,	
(en 6 43 6 1277,1390,4804,4816,9436,9549,	
han 22 43 22 639,843,1008,1041,1271,2004,2050,2115,2222,2255,3092,3101,3127,3471,3503,4113,5732,8798,9002,9167,9200,9430,	
limitados 5 43 5 632,836,1599,8791,8995,	
8) 6 43 6 910,1089,7022,7056,9069,9248,	
extrapolación 5 43 5 629,833,7900,8788,8992,	
basados 4 43 4 626,830,8785,8989,	
están 6 43 6 625,829,1677,1782,8784,8988,	
propuestos 4 43 4 624,828,8783,8987,	
ajustes 4 43 4 621,825,8780,8984,	
Los 31 43 31 620,824,967,1237,1336,1354,1900,2111,2218,3509,3799,3900,4310,4784,4820,4832,5486,5515,5570,6021,6121,6319,6404,6548,6589,8779,8983,9126,9396,9495,9513,	
dosificación 2 43 2 612,8771,	
intervalos 4 43 4 610,1096,8769,9255,	
21 1 43 1 7577,	
aumentando 2 43 2 608,8767,	
alternativa 2 43 2 604,8763,	
guanosina 1 43 1 3594,	
disponible 4 43 4 600,1930,8172,8759,	
estuviera 2 43 2 599,8758,	
caso 8 43 8 592,1220,3506,3536,3776,6704,8751,9379,	
tabla 8 43 8 588,619,4386,4634,6256,6966,8747,8778,	
detalla 2 43 2 585,8744,	
según 3 43 3 583,2433,8742,	
solución 8 43 8 581,596,756,1932,6593,8740,8755,8915,	
(60 1 43 1 7082,	
utilizando 3 43 3 577,3839,8736,	
diaria 4 43 4 576,1895,6887,8735,	
precisan 2 43 2 1409,9568,	
(DPAC) 3 43 3 568,6958,8727,	
correspondían 1 43 1 7419,	
continua 3 43 3 567,6957,8726,	
local 1 43 1 8110,	
ambulatoria 3 43 3 566,6956,8725,	
inhibe 2 43 2 3629,3739,	
peritoneal 3 43 3 565,6955,8724,	
alcanzaban 1 43 1 3289,	
diálisis 2 43 2 564,8723,	
reducción 7 43 7 572,3055,4139,5627,5662,7596,8731,	
hemodiálisis 7 43 7 562,763,770,6941,8721,8922,8929,	
sometidos 3 43 3 560,7622,8719,	
aquéllos 2 43 2 559,8718,	
Receptores 1 43 1 1593,	
incluidos 3 43 3 558,7454,8717,	
ml/min 3 43 3 557,6834,8716,	
50 7 43 7 556,669,2674,2878,7073,8715,8828,	
experimentaron 4 43 4 3150,3267,3531,6221,	
< 27 43 27 555,713,749,2454,2595,2631,2636,2673,2677,2814,2877,2881,4341,4796,4904,4956,5033,5098,5120,5184,5357,5402,5498,5567,8714,8872,8908,	
Se 16 43 16 543,569,1702,1827,2126,2206,2626,2843,3073,5731,6155,6496,7512,7840,8702,8728,	
máximo 3 43 3 4885,5079,5338,	
creatinina 10 43 10 538,554,665,6937,6989,7183,7288,8697,8713,8824,	
disminuir 3 43 3 533,6933,8692,	
disminuye 4 43 4 531,4037,6931,8690,	
aclaramiento 11 43 11 528,535,552,6821,6928,6935,7181,7286,8687,8694,8711,	
Insuficiencia 8 43 8 525,771,805,6901,6925,8684,8930,8964,	
etnia 2 43 2 524,8683,	
sexo 4 43 4 521,3386,5438,8680,	
ajuste 4 43 4 515,816,8674,8975,	
étnico 4 43 4 510,7339,7348,8669,	
Sexo 3 43 3 507,7151,8666,	
renal"" 2 43 2 502,8661,	
lipasa 2 43 2 2658,2862,	
""Insuficiencia 2 43 2 501,8660,	
recomendaciones 2 43 2 497,8656,	
dependiendo 2 43 2 489,8648,	
ajustarse 2 43 2 488,8647,	
náuseas 5 43 5 1342,2415,2522,2750,9501,	
análogo 3 43 3 1303,3592,9462,	
La 21 43 21 485,1090,1575,1615,2309,3672,3768,4020,4133,4245,5193,6234,6470,6609,6684,6740,7132,8085,8165,8644,9249,	
edad 10 43 10 482,2162,3397,5450,7201,7214,7238,7316,7325,8641,	
función 20 43 20 479,492,519,1091,1162,1616,1972,2026,3080,3431,5436,6922,7129,7169,7274,8638,8651,8678,9250,9321,	
ajustar 10 43 10 475,545,605,776,7176,7281,8634,8704,8764,8935,	
fumarato 2 43 2 2001,5524,	
necesario 8 43 8 474,513,775,2145,3553,8633,8672,8934,	
Ancianos 3 43 3 471,7194,8630,	
seguridad 16 43 16 468,635,839,1605,2372,2488,2708,2718,2912,3328,3358,3380,7389,8627,8794,8998,	
ausencia 5 43 5 464,1278,4116,8623,9437,	
debido 9 43 9 461,1420,5790,6014,6306,7163,7268,8620,9579,	
18 5 43 5 459,3704,6681,8580,8618,	
menores 4 43 4 457,3875,6781,8616,	
anti-HIV 1 43 1 3965,	
niños 3 43 3 456,8055,8615,	
recomendado 2 43 2 452,8611,	
adolescentes 2 43 2 448,8607,	
Niños 2 43 2 446,8605,	
paciente 8 43 8 445,484,495,3544,5779,8604,8643,8654,	
apropiado 2 43 2 442,8601,	
principalmente 1 43 1 7267,	
actividades 2 43 2 2286,3633,	
sigue 2 43 2 440,8599,	
continuar 2 43 2 437,8596,	
asegurar 2 43 2 435,8594,	
probablemente 1 43 1 7835,	
858) 1 43 1 2354,	
periódica 3 43 3 433,3077,8592,	
reevaluación 2 43 2 432,8591,	
indica 2 43 2 616,8775,	
recomienda 13 43 13 430,544,570,754,814,1773,2234,3074,8589,8703,8729,8913,8973,	
años 12 43 12 428,460,5547,7219,7225,7243,7249,7321,7763,7948,8587,8619,	
prolongados 2 43 2 423,8582,	
tratamientos 2 43 2 422,8581,	
Con 2 43 2 420,8579,	
esteatosis 4 43 4 1269,1290,9428,9449,	
10-29 2 43 2 698,8857,	
negativos 11 43 11 397,1085,1823,2482,3227,4419,5070,5319,7735,8556,9244,	
4) 8 43 8 393,3120,3370,3919,5801,7024,7150,8552,	
eficacia 18 43 18 389,419,470,637,841,1602,1655,1817,4275,4539,4736,5432,6717,8548,8578,8629,8796,9000,	
basales 3 43 3 4312,4358,5692,	
pérdida 8 43 8 387,417,3911,4801,4932,4984,8546,8576,	
haya 4 43 4 384,414,8543,8573,	
HBs 4 43 4 380,410,8539,8569,	
meses) 2 43 2 375,8534,	
- 15 43 15 373,3032,3212,3795,6466,6522,6532,6652,6672,6682,6832,6871,7217,7241,8532,	
separadas 2 43 2 367,8526,	
esternón 1 43 1 7609,	
suero 2 43 2 366,8525,	
consecutivas 2 43 2 364,8523,	
muestras 3 43 3 363,4129,8522,	
anticuerpos 2 43 2 359,8518,	
detección 2 43 2 357,8516,	
ADN 27 43 27 352,904,1029,3654,3669,3727,3743,4482,4683,4901,4953,5030,5095,5117,5181,5354,5399,5664,5889,6085,6138,6368,6422,7730,8511,9063,9188,	
HBe 4 43 4 346,360,8505,8519,	
seroconversión 12 43 12 345,379,409,4919,4926,4971,4978,5373,5700,8504,8538,8568,	
cumplían 2 43 2 4765,4835,	
(pérdida 2 43 2 347,8506,	
produzca 4 43 4 343,407,8502,8566,	
administrarse 6 43 6 335,401,766,8494,8560,8925,	
positivos 7 43 7 333,4413,4568,4876,5329,5477,8492,	
En 46 43 46 330,394,590,911,935,1049,1122,1187,1501,1525,2366,2964,3121,3185,3228,3276,3535,3879,3920,3949,4207,4384,4560,4632,4935,5650,5753,5898,6964,7390,7475,7555,7583,7620,7644,7660,8489,8553,8749,9070,9094,9208,9281,9346,9660,9684,	
siguiente 6 43 6 329,589,6255,6967,8488,8748,	
cuenta 2 43 2 327,8486,	
interrupción 4 43 4 320,1236,8479,9395,	
óptima 2 43 2 315,8474,	
duración 5 43 5 314,1570,2696,2900,8473,	
desconoce 4 43 4 312,2127,2207,8471,	
Duración 4 43 4 308,2682,2886,8467,	
virológica 12 43 12 648,852,1516,4177,4334,4366,4790,4840,4861,8807,9011,9675,	
2) 15 43 15 307,506,542,823,1643,1962,2079,4534,4731,6726,7018,8466,8665,8701,8982,	
copias/ml 12 43 12 4326,4492,4691,4906,4958,5035,5100,5122,5186,5359,5404,5675,	
apartado 25 43 25 305,391,540,821,908,1087,1590,1641,1738,1807,1960,2077,2123,3118,3368,3917,5799,6724,7148,8464,8550,8699,8980,9067,9246,	
(E433) 1 43 1 7936,	
comida) 2 43 2 303,8462,	
Ishak 4 43 4 4445,4460,4657,4668,	
después 11 43 11 300,767,1113,1233,3086,3482,4181,8459,8926,9272,9392,	
horas 13 43 13 293,299,745,3620,6469,6655,6662,6873,6900,6944,8452,8458,8904,	
(más 2 43 2 290,8449,	
30°C 1 43 1 7962,	
ayunas 2 43 2 289,8448,	
limita 3 43 3 1168,3437,9327,	
[LVDr]) 2 43 2 276,8435,	
resistencia 21 43 21 272,1480,1497,1539,3807,4034,4097,4121,4134,5848,5915,5951,5985,6186,6199,6235,6283,8431,9639,9656,9698,	
confieren 10 43 10 271,1479,3806,4033,4096,4120,5914,5950,8430,9638,	
mutaciones 9 43 9 269,1468,1583,3804,4586,6125,6408,8428,9627,	
144 6 43 6 1573,5935,5966,6215,6245,6266,	
durante 47 43 47 262,424,926,993,1107,1215,1230,1245,1564,1623,2138,2237,2355,2505,2734,2914,2926,2971,3026,3082,3181,3272,3477,3517,4778,4826,4883,5077,5336,5541,5603,5614,5881,6050,6088,6333,6371,7464,7490,8421,8583,9085,9152,9266,9374,9389,9404,	
107 1 43 1 2360,	
viremia 3 43 3 261,5503,8420,	
indicios 5 43 5 259,3548,7498,7697,8418,	
decir 2 43 2 257,8416,	
(es 2 43 2 256,8415,	
resistentes 17 43 17 253,1464,1709,2712,2968,3232,3781,3995,4557,4572,5324,6158,6248,6271,6720,8412,9623,	
alcanzar 1 43 1 6850,	
alimentos 4 43 4 251,6657,6696,8410,	
equilibrio 1 43 1 6812,	
HBsAg 2 43 2 4928,4980,	
o 66 43 66 249,267,295,376,381,411,522,563,730,791,963,1248,1330,1562,1638,1648,1669,1916,1974,2021,2059,2350,3065,3173,3395,3811,3934,3979,4030,4059,4064,4069,4619,4776,4808,4844,5447,5598,5896,6095,6110,6149,6378,6393,6432,6631,6757,6776,6912,7115,7507,7816,8408,8426,8454,8535,8540,8570,8681,8722,8889,8950,9122,9407,9489,9721,	
recomendada 4 43 4 238,279,8397,8438,	
carácter 2 43 2 1508,9667,	
dosis 49 43 49 237,278,477,486,499,517,547,575,607,623,748,778,819,827,1894,2120,3524,5856,6033,6503,6516,6560,6576,6819,6827,6949,6976,7110,7395,7416,7449,7527,7675,8006,8031,8396,8437,8636,8645,8658,8676,8706,8734,8766,8782,8907,8937,8978,8986,	
Pacientes 21 43 21 230,252,658,1136,1671,1777,3405,4868,4874,5068,5323,5327,5461,5703,5802,5976,6274,8389,8411,8817,9295,	
día 20 43 20 229,247,287,676,682,697,2504,2733,4609,4628,5594,5830,5838,6541,8388,8406,8446,8835,8841,8856,	
vez 35 43 35 227,245,285,674,680,688,695,703,710,719,726,1250,2502,2731,4501,4607,4626,4700,5199,5592,5828,5836,6539,8386,8404,8444,8833,8839,8847,8854,8862,8869,8878,8885,9409,	
oral 10 43 10 225,582,597,757,1933,6594,8384,8741,8756,8916,	
vía 3 43 3 224,2019,8383,	
tomarse 2 43 2 222,8381,	
experiencia 2 43 2 211,8370,	
médico 2 43 2 209,8368,	
iniciado 2 43 2 206,8365,	
debe 31 43 31 204,221,324,334,400,487,649,765,853,1093,1510,1618,1745,1848,2037,2136,2191,3541,4136,5785,8363,8380,8483,8493,8559,8646,8808,8924,9012,9252,9669,	
El 14 43 14 202,2485,2715,3818,4152,4759,6525,6820,6874,7255,7305,7794,7892,8361,	
x 11 43 11 2789,2824,2850,2865,2937,2982,4316,7992,8011,8017,8036,	
efecto 6 43 6 2174,2283,4103,7198,7418,7885,	
administración 11 43 11 201,1294,2535,2763,6513,6537,6610,6765,6885,8360,9453,	
forma 5 43 5 199,3608,5491,7440,8358,	
Posología 4 43 4 197,653,8356,8812,	
1) 9 43 9 194,1592,1740,1809,7058,7062,7083,7085,8353,	
combinada 2 43 2 6048,6331,	
presentó 5 43 5 2554,2584,2782,2802,5699,	
secciones 2 43 2 189,8348,	
descender 2 43 2 899,9058,	
(ver 30 43 30 188,304,390,496,539,820,907,1086,1589,1640,1737,1806,1959,2076,2122,3117,3367,3916,5798,5937,6723,7147,8347,8463,8549,8655,8698,8979,9066,9245,	
lamivudina 62 43 62 187,255,266,275,664,1466,1482,1506,1537,1805,1995,2057,2351,2376,2714,2963,2970,3008,3149,3234,3266,3352,3783,3931,3997,4123,4409,4517,4559,4574,4594,4622,4645,4714,4939,5026,5067,5138,5154,5177,5222,5275,5305,5326,5514,5540,5578,5953,6174,6193,6250,6273,6722,8346,8414,8425,8434,8823,9625,9641,9665,9696,	
resistente 5 43 5 185,1504,4154,8344,9663,	
(< 7 43 7 1843,4490,4689,5044,5988,5991,5994,	
nucleósidos 28 43 28 179,235,668,1060,1298,1318,1386,2479,2925,3132,3196,3574,3973,4309,4350,4378,4428,4873,5906,5975,6711,8338,8394,8827,9219,9457,9477,9545,	
previo 21 43 21 177,233,661,1058,2477,2923,3130,3194,4376,4426,4871,5538,5865,5904,5973,6191,6709,8336,8392,8820,9217,	
negativa 2 43 2 171,8330,	
HBeAg 33 43 33 169,173,332,349,396,1084,1822,3226,4352,4415,4421,4509,4570,4706,4803,4806,4818,4875,4921,4973,5069,5318,5328,5375,5476,5481,5702,8328,8332,8491,8508,8555,9243,	
positiva 2 43 2 167,8326,	
VHB 47 43 47 166,354,906,1031,1474,1869,2181,2205,3366,3602,3645,3671,3681,3745,3764,3780,3992,4150,4153,4322,4340,4484,4685,4792,4795,4903,4955,5032,5097,5119,5183,5356,5401,5506,5633,5666,5891,6087,6140,6370,6424,7106,8325,8513,9065,9190,9633,	
pacientes 161 43 161 161,174,181,331,395,550,780,809,897,913,936,968,1006,1051,1083,1141,1160,1171,1188,1238,1389,1408,1463,1530,1659,1688,1716,1749,1821,1833,1852,1901,2042,2329,2474,2553,2599,2640,2655,2681,2711,2781,2818,2859,2885,2920,2951,2960,2967,2996,3005,3011,3099,3124,3137,3146,3187,3225,3231,3243,3256,3288,3321,3336,3362,3401,3410,3429,3440,4131,4249,4278,4304,4345,4363,4373,4412,4521,4556,4567,4584,4591,4718,4805,4817,4821,4833,4855,4936,4993,5013,5023,5056,5135,5145,5211,5225,5261,5290,5301,5317,5379,5420,5455,5475,5487,5530,5561,5571,5652,5689,5698,5718,5741,5817,5852,5901,5930,5970,6043,6068,6076,6122,6171,6220,6247,6270,6351,6359,6405,6706,6719,6907,6920,6982,7146,7311,8320,8333,8340,8490,8554,8709,8939,8968,9056,9072,9095,9127,9165,9210,9242,9300,9319,9330,9347,9397,9548,9567,9622,9689,	
animales 3 43 3 2114,2221,7489,	
obtenidos 2 43 2 159,8318,	
clínicos 11 43 11 158,1197,2320,3279,3469,3836,4051,4189,5844,8317,9356,	
ensayos 20 43 20 157,2319,2368,2918,2965,3122,3229,3278,3393,3468,4188,4210,4397,5445,5843,5899,5968,6241,6268,8316,	
Ninguna 1 43 1 8083,	
datos 13 43 13 155,466,631,835,1598,1652,1814,2101,2171,8314,8625,8790,8994,	
basa 6 43 6 153,2316,2490,2720,4172,8312,	
indicación 2 43 2 151,8310,	
Esta 6 43 6 150,1165,3434,7439,8309,9324,	
fibrosis 8 43 8 149,4242,4253,4443,4454,4655,4664,8308,	
histología 2 43 2 4523,4720,	
y/o 4 43 4 148,4066,5922,8307,	
inflamación 3 43 3 146,7401,8305,	
histológicas 2 43 2 144,8303,	
pruebas 11 43 11 143,385,415,1104,2385,2546,2774,8302,8544,8574,9263,	
elevados 2 43 2 141,8300,	
persistentemente 2 43 2 140,8299,	
sérica 10 43 10 139,883,892,946,962,8298,9042,9051,9105,9121,	
(ALT) 2 43 2 138,8297,	
aminotransferasa 2 43 2 137,8296,	
alanina 2 43 2 136,8295,	
(19%) 1 43 1 6290,	
niveles 15 43 15 134,880,901,1027,4311,5028,5179,5397,5691,6852,7883,8293,9039,9060,9186,	
mayores 1 43 1 7426,	
activa 6 43 6 133,147,1981,3609,8292,8306,	
vírica 3 43 3 132,4206,8291,	
45 3 43 3 1170,3439,9329,	
replicación 4 43 4 131,4160,4205,8290,	
fertilidad 1 43 1 7503,	
evidencia 3 43 3 129,4203,8288,	
compensada 8 43 8 127,940,1164,3433,4383,8286,9099,9323,	
94% 1 43 1 5092,	
hepática 35 43 35 126,772,783,939,966,978,1092,1163,1208,1244,1291,1368,1406,3081,3432,4281,4382,5805,5820,6902,6910,6923,8285,8931,8942,9098,9125,9137,9251,9322,9367,9403,9450,9527,9565,	
enfermedad 10 43 10 125,938,1405,4280,4381,5804,5819,8284,9097,9564,	
adultos 4 43 4 123,1793,4197,8282,	
(VHB) 2 43 2 121,8280,	
B 23 43 23 120,184,218,867,1015,1121,1132,1205,1456,1720,2332,3111,4200,6985,8279,8343,8377,9026,9174,9280,9291,9364,9615,	
hepatitis 34 43 34 119,183,217,860,866,984,1004,1014,1120,1131,1204,1397,1455,1646,1667,1719,2331,3097,3110,4199,6984,8278,8342,8376,9019,9025,9143,9163,9173,9279,9290,9363,9556,9614,	
virus 9 43 9 116,1473,1664,3107,3800,3994,4084,8275,9632,	
crónica 11 43 11 113,219,868,1457,1721,2333,4201,8272,8378,9027,9616,	
infección 8 43 8 112,163,1718,1724,1767,2200,8271,8322,	
tratamiento 124 43 124 109,176,203,214,232,264,310,317,322,337,399,439,660,888,928,995,1011,1057,1117,1128,1184,1217,1226,1247,1314,1425,1559,1625,1680,1697,1731,1764,1785,1860,2239,2335,2428,2476,2495,2581,2684,2690,2725,2799,2888,2894,2916,2922,2928,2973,3028,3043,3084,3090,3104,3114,3129,3193,3281,3297,3452,4186,4232,4370,4375,4425,4758,4760,4783,4831,4849,4866,4870,4880,4990,4998,5074,5192,5205,5333,5383,5424,5537,5586,5658,5726,5864,5883,5903,5972,6058,6090,6190,6209,6341,6373,6708,8268,8335,8362,8373,8391,8423,8469,8476,8481,8496,8558,8598,8819,9047,9087,9154,9170,9216,9276,9287,9343,9376,9385,9406,9473,9584,9718,	
indicado 2 43 2 106,8265,	
está 6 43 6 105,451,5808,8171,8264,8610,	
compensada) 1 43 1 4282,	
Baraclude 13 43 13 104,220,449,580,755,1935,2134,2241,8263,8379,8608,8739,8914,	
terapéuticas 2 43 2 103,8262,	
Indicaciones 2 43 2 102,8261,	
	"4 2 43 2 100,8259,	
pulmonares 2 43 2 7775,7829,	
CLÍNICOS 2 43 2 99,8258,	
DATOS 3 43 3 98,7907,8257,	
4 45 43 45 97,190,191,195,392,784,797,798,822,909,931,1088,1938,2094,2242,2305,3031,3119,3369,3498,3918,4258,5545,5800,6566,6725,6943,7005,7011,7149,7494,7778,7950,8256,8349,8350,8354,8551,8943,8956,8957,8981,9068,9090,9247,	
" 4 43 4 96,3561,8255,9723,	
""1611"" 1 43 1 92,	
cara 2 43 2 90,8249,	
espontáneas 2 43 2 863,9022,	
grabado 2 43 2 87,8246,	
""BMS"" 2 43 2 86,8245,	
blanquecino 1 43 1 84,	
70% 1 43 1 6495,	
blanco 1 43 1 82,	
triangular 2 43 2 81,8242,	
Comprimido 2 43 2 80,8241,	
(comprimido) 2 43 2 79,8240,	
recubierto 2 43 2 76,8237,	
	"Comprimido 2 43 2 75,8236,	
FARMACÉUTICA 2 43 2 74,8235,	
FORMA 2 43 2 73,8234,	
3 22 43 22 72,372,707,785,2589,2645,2660,2849,2864,3632,6216,6570,7009,7051,7070,7385,7943,8000,8233,8531,8866,8944,	
6 22 43 22 70,374,1111,1231,2095,6531,6627,7013,7049,7072,7074,7906,7937,7942,7949,7981,8077,8078,8231,8533,9270,9390,	
sección 4 43 4 69,504,8230,8663,	
mostraron 2 43 2 3909,4364,	
ver 3 43 3 68,5048,8229,	
competir 1 43 1 3622,	
excipientes 5 43 5 67,796,7913,8228,8955,	
completa 2 43 2 65,8226,	
lista 2 43 2 64,8225,	
consultar 2 43 2 62,8223,	
Para 8 43 8 61,318,1413,1925,5223,8222,8477,9572,	
renal 22 43 22 493,526,806,812,1210,1370,1617,1973,2020,2027,6822,6926,7130,7134,7170,7275,8652,8685,8965,8971,9369,9529,	
lactosa 4 43 4 60,1891,1937,8221,	
acerca 1 43 1 2172,	
120 2 43 2 56,1887,	
Excipientes 2 43 2 52,8214,	
monohidrato) 2 43 2 51,8213,	
(como 2 43 2 50,8212,	
entecavir 133 43 133 49,530,764,916,1054,1186,1300,1499,1541,1561,1607,1627,1657,1682,1711,1747,1787,1819,1862,1952,2012,2029,2055,2086,2107,2176,2209,2227,2262,2277,2337,2344,2374,2406,2430,2497,2693,2727,2897,2954,2999,3014,3116,3140,3190,3259,3283,3330,3360,3382,3454,3481,3588,3713,3738,3773,3817,3825,3885,3899,3915,3942,3957,4019,4036,4041,4075,4099,4109,4404,4603,4882,5016,5059,5076,5148,5169,5214,5265,5294,5335,5385,5434,5533,5588,5621,5638,5660,5712,5748,5783,5824,5858,5917,5933,6038,6060,6160,6177,6211,6237,6343,6454,6616,6734,6751,6767,6793,6840,6858,6930,6973,7096,7143,7206,7337,7359,7462,7487,7565,7669,7685,7690,8211,8689,8923,9075,9213,9345,9459,9658,9700,9720,	
contiene 8 43 8 44,55,1886,7990,8057,8065,8207,8217,	
comprimido 5 43 5 43,54,7916,8206,8216,	
completamente 1 43 1 1588,	
	Cada 2 43 2 42,8205,	
CUANTITATIVA 2 43 2 41,8204,	
Y 2 43 2 40,8203,	
CUALITATIVA 2 43 2 39,8202,	
COMPOSICIÓN 2 43 2 38,8201,	
2 31 43 31 37,196,292,298,421,2574,2604,2615,2621,2632,2823,3060,3162,4220,4315,6309,6450,6567,6583,6638,6882,7045,7068,7121,7789,7938,7947,8200,8355,8451,8457,	
película 5 43 5 36,78,8062,8199,8239,	
96% 1 43 1 5164,	
recubiertos 5 43 5 34,7995,8020,8060,8197,	
comprimidos 8 43 8 33,6590,7994,8013,8019,8038,8059,8196,	
mg 52 43 52 32,47,58,243,283,672,678,686,693,701,708,717,724,736,742,752,1889,1899,2500,2729,3529,4605,4624,5590,5826,5834,5862,5871,6036,6524,6564,6579,6614,6980,7437,7787,8195,8209,8219,8402,8442,8831,8837,8845,8852,8860,8867,8876,8883,8895,8901,8911,	
5 56 43 56 31,46,57,193,242,306,505,541,671,692,735,741,751,933,1591,1642,1739,1808,1888,1898,1939,1961,2078,2124,2339,2499,2633,3033,3562,5560,5861,6449,6465,6468,6563,6586,6613,6654,7007,7030,7032,7384,7434,7786,7982,8352,8401,8465,8664,8700,8830,8851,8894,8900,8910,9092,	
UB8 1 43 1 8128,	
	Baraclude 2 43 2 29,8193,	
MEDICAMENTO 3 43 3 28,3567,8192,	
interrumpirse 2 43 2 1312,9471,	
NOMBRE 2 43 2 26,8190,	
1 56 43 56 24,25,71,101,282,677,723,2327,2345,2728,3569,4127,4195,4500,4604,4699,4811,5047,5198,5480,5589,5825,5869,5987,5990,5993,6006,6035,6128,6225,6412,6467,6521,6523,6578,6653,6979,7003,7066,7436,7465,7551,7792,7910,7993,8012,8018,8037,8189,8194,8208,8232,8260,8441,8836,8882,	
alcanzadas 5 43 5 7429,7472,7538,7580,7781,	
PRODUCTO 1 43 1 23,	
DEL 4 43 4 22,27,8163,8191,	
grupo 3 43 3 509,5656,8668,	
CARACTERÍSTICAS 1 43 1 21,	
LAS 1 43 1 20,	
DE 9 43 9 19,3565,8113,8116,8134,8136,8146,8150,8160,	
RESUMEN 1 43 1 18,	
O 1 43 1 17,	
absorción 1 43 1 6650,	
TÉCNICA 1 43 1 16,	
FICHA 1 43 1 15,	
tuvo 2 43 2 1568,3715,	
ocasiones 2 43 2 1282,9441,	
información 3 43 3 12,1830,8166,	
Toda 1 43 1 10,	
medicamento 8 43 8 9,14,1885,1924,3464,6692,8088,8170,	
Basica 1 43 1 7,	
células/mm3 1 43 1 5557,	
	Información 1 43 1 6,	
ORAL 1 43 1 5,	
SOLUCION 1 43 1 4,	
TP 1 43 1 3688,	
210ML 1 43 1 3,	
05MG/ML 1 43 1 2,	
demostración 1 43 1 4167,	
0 53 43 53 1,30,45,241,670,684,691,699,706,715,722,734,740,750,1897,2338,2498,3684,3754,3789,3793,3796,3857,4324,4518,4715,4797,5646,5860,5870,6002,6004,6464,6520,6562,6569,6585,6612,6660,6962,7433,7785,8400,8829,8843,8850,8858,8865,8874,8881,8893,8899,8909,	
Entre 1 43 1 3009,	
BARACLUDE 1 43 1 0,	
